Equity Details
Price & Market Data
Price: $6.26
Daily Change: +$0.12 / 1.92%
Daily Range: $6.10 - $6.34
Market Cap: $1,080,739,200
Daily Volume: 1,574,265
Performance Metrics
1 Week: 0.48%
1 Month: 4.86%
3 Months: -13.30%
6 Months: -15.75%
1 Year: 26.46%
YTD: -20.25%
About Xeris Biopharma Holdings, Inc. (XERS)
Detailed report on Xeris Biopharma Holdings, Inc. (XERS). Current price: 6.26, daily change: +$0.12 / 1.92%. Market cap: 1,080,739,200. Explore all performance metrics.
Company Details
Employees: 435
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. It offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.